RT Journal Article
SR Electronic
T1 Controlled trial of disodium cromoglycate in chronic persistent ulcerative colitis.
JF Gut
JO Gut
FD BMJ Publishing Group Ltd and British Society of Gastroenterology
SP 1140
OP 1143
DO 10.1136/gut.19.12.1140
VO 19
IS 12
A1 N A Buckell
A1 S R Gould
A1 D W Day
A1 J E Lennard-Jones
A1 A M Edwards
YR 1978
UL http://gut.bmj.com/content/19/12/1140.abstract
AB Oral disodium cromoglycate (200 mg qds) has been tested in 26 patients with ulcerative colitis that was resistant to medical treatment. In a double-blind crossover trial disodium cromoglycate and placebo were added to conventional treatment in random order, each for four weeks. There was no significant difference in therapeutic effect between disodium cromoglycate and placebo.